期刊文献+

18F-FLT和18F-FDG PET/CT对胸段食管癌淋巴结分期诊断的对比研究 被引量:14

Comparison of 18F-FLT and 18F-FDG PET/CT for lymph node staging in thoracic esophageal carcinoma
原文传递
导出
摘要 目的 评价18F-脱氧胸苷(FLT)PET/CT对未经治疗的胸段食管癌淋巴结分期诊断的价值,并与18F-脱氧葡萄糖(FDG)PET/CT进行比较.方法 选择22例拟行手术治疗的胸段食管癌患者,术前行双显像剂PET/CT检查及淋巴结分期诊断,术后以病理学诊断为"金标准",比较18F-FLT和18F-FDG PET/CT对胸段食管癌淋巴结分期的灵敏度、特异性、准确性、阳性预测值和阴性预测值.应用SPSS 13.0软件进行x2检验.结果 患者均行食管癌切除和淋巴结清扫术,病理检查结果显示16例患者存在淋巴结转移,N0期7例,N1期15例,M1a期6例(其中1例为N0M1a,另外5例为N1M1a),全组均无M1b期.共检出424枚淋巴结,其中47枚为转移淋巴结.18F-FDG PET/CT诊断呈假阳性的淋巴结14枚,而18F-FLT诊断呈假阳性的淋巴结为3枚;18F-FDG假阴性的淋巴结8枚,18F-FLT假阴性的淋巴结12枚.18F-FLT PET/CT的诊断灵敏度、特异性、准确性、阴性预测值和阳性预测值分别为74.47%(35/47)、99.20%(374/377)、96.46%(409/424)、96.89%(374/386)和92.11%(35/38),18F-FDG分别为82.98%(39/47)、96.29%(363/377)、94.81%(402/424)、97.84%(363/371)和73.58%(39/53);两者比较的x2值分别为0.572,6.018,1.017,0.348,3.852,P值分别>0.05,<0.05、>0.05、>0.05和>0.05.结论 18F-FLT对食管癌区域淋巴结的诊断灵敏度与18F-FDG显像接近,特异性高于18F-FDG,但仍存在一定的局限性. Objective To compare the diagnostic value 18F-fluorothymidine (FLT) and 18F-fluorodeoxyglucose (FDG) PET/CT in detecting lymph node metastases of untreated thoracic esophageal carcinoma. Methods Twenty-two patients with thoracic esophageal squamous cell carcinoma underwent both 18F-FLT and 18F-FDG PET/CT before surgery. The imaging results of the two modalities in detecting regional lymph node metastases were compared prospectively with the pathologic findings. The X2-test was used with SPS S 13.0. Results All patients underwent esophagectomy and lymphadenectomy. The metastatic lymph nodes were found in 16 patients, from which 47 of 424 excised nodes were positive by pathologic examination. False positive results were 14 while false negative 8 on 18F-FDG PET/CT. In contrast, false positive results were only 3 but false negative were 12 on 18 F-FLT PET/CT. The sensitivity, specificity, accuracy,negative predictive value, and positive predictive value were 74.47% ( 35/47 ), 99.20% ( 374/377 ),96.46% (409/424), 96.89% ( 374/386 ) and 92.11% ( 35/38 ) respectively for 18 F-FLT PET/CT, whereas the corresponding values were 82.98% (39/47), 96.29% (363/377), 94.81% (402/424), 97.84%(363/371 ) and 73.58% (39/53) respectively for 18 F-FDG PET/CT (X2 = 0.572, 6.018, 1.017, 0.348,3.852, P〉0. 05, 〈0.05, 〉0.05, 〉0.05 and 〉0.05). Conclusions Compared with 18F-FDG PET/CT, 18F-FLT PET/CT may be less sensitive but more specific for the detection of lymph node metastases of thoracic esophageal carcinoma.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2010年第6期383-386,共4页 Chinese Journal of Nuclear Medicine
基金 2009-2010年山东省医药卫生科技发展计划青年基金(2009QZ028)
关键词 食管肿瘤 肿瘤转移 淋巴结 体层摄影术 发射型计算机 体层摄影术 X线计算机 胸苷 脱氧葡萄糖 Esophageal neoplasms Neoplasm metastasis Lymph nodes Tomography,emission-computed Tomography, X-ray computed Thymidine Deoxyglucose
  • 相关文献

参考文献19

  • 1Buenaventura P,Luketich JD.Surgical staging of esophageal cancer.Chest Surg Clin N Am,2000,10:487-497.
  • 2Westerterp M,vanWestreenen HL,Reitsma JB,et al.Esophageal cancer:CT,endoscopic US,and FDG PET for assessment of response to neoadjuvant therapy systematic review.Radiology,2005,236:841-851.
  • 3Arslan N,Miller TR,Dehdashti F,et al.Evaluation of response to neoadjuvant theravy by quantitative 2-deoxy-2-18 F-fluoro-D-glucose with positron emission tomography in patients with esophageal cancer.Mol Imaging Biol,2002,4:301-310.
  • 4Nakamura R,Obara T,Katsuragawa S,et al.Failure in presumption of residual disease by quantification of FDG uptake in esophageal squamous cell carcinoma immediately after radiotherapy.Radiat Med,2002,20:181-186.
  • 5Waldherr C,Mellinghoff IK,Tran C,et al.Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET.J Nucl Med,2005,46:114-120.
  • 6Buck AK,Halter G,Schirrmeister H,et al:Imaging proliferation in lung tumors with PET:18F-FLT versus 18F-FDG.J Nucl Med,2003,44:1426-1431.
  • 7Barthel H,Cleij MC,Collingridge DR,et al.3'deoxy-3'-18F-fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.Cancer Res,2003,63:3791-3798.
  • 8van Waarde A,Cobben DCP,Suurmeijer AJH,et al.Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.J Nucl Med,2004,45:695-700.
  • 9Tian JH,Yang XF,Yu LJ,et al.A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3 '-deoxy-3'-18F-fluorothymidine and 18F-FDG.J Nucl Med,2008,49:186-194.
  • 10F.L.格林尼,D.L.佩基,I.D.弗莱明,等.AJCC癌症分期手册.6版.毛伟征,苏东明,李雪萍,等,译.沈阳:辽宁科学技术出版社,2005:91-98.

二级参考文献41

  • 1孙晓蓉,邢力刚,于金明,付政,马莉,赵书强,陈鲁生,李文武,杨国仁.肺部肿瘤PET/CT同机图像融合精度研究[J].中华核医学杂志,2004,24(5):302-304. 被引量:11
  • 2赵军,林祥通.关于PET/CT临床应用的若干问题[J].中华核医学杂志,2005,25(2):69-71. 被引量:17
  • 3陈盛祖.PET/CT的若干技术问题[J].中华核医学杂志,2005,25(2):72-74. 被引量:12
  • 4杨文锋,于金明,李道堂.FDG PET显像对非小细胞肺癌纵隔淋巴结转移的检测[J].中华核医学杂志,2006,26(2):120-122. 被引量:9
  • 5Czemin J, Weber W. Translational molecular imaging. Mol Imaging Biol, 2004, 6: 181-182.
  • 6Even-Sapir E, Parag Y, Lerman H, et al. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology, 2004, 232: 815-822.
  • 7Aquino SL, Asmuth JC, Alpert NM, et al. Improved radiologie staging of lung cancer with 2-^18F-fluoro-2-deoxy-D-glucose-positron emission tomography and computed tomography registration. J Comput Assist Tomogr, 2003, 27 : 479-484.
  • 8Prenzel KL, Monig SP, Sinning JM, et al. Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest, 2003, 123 : 463-467.
  • 9Herth F, Ernst A, Schulz M, et al. Endobronchial ultrasound reliably differentiates between airway infiltration and compression by tumor. Chest, 2003, 123: 458-462.
  • 10Deniaud-Alexandre E, Touboul E, Lerouge D, et al. Impact of computed tomography and 18F-deoxyglucose coincidence detection emision tomagraphy image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 2005, 63: 1432-1441.

共引文献21

同被引文献101

引证文献14

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部